Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long needles has been achieved by breaking the stacking effect with the help of co-formers. Eight new co-crystals are reported, along with three crystal structures. In all cases, ortho F disorder, often a feature in diflunisal structures was absent due to the presence of CH…F interactions. Co-milling diflunisal with oxalic acid produced 1:1 and 2:1 co-crystals. In contrast, in solution crystallisation oxalic acid played the role of an additive resulting in the crystallisation of diflunisal form I rather than form III. To rationalize co-crystal formation a statistical analysis of the CCDC data base for aromatic o-hydroxy carboxylic acids was carried out. All co-crystals of o-hydroxy carboxylic acids with the COOH dimer motif have an electron-withdrawing group on one of the acids. COOH…Nar motifs are formed preferentially over carboxylic homo-dimers in the presence of an Nar co-former. 
Introduction
Needle like crystals of drugs not only tend to have dissolution issues, but are also known to pose a challenge to processing because they have poor flow properties and form tablets of variable densities. 1 crystal adducts of diflunisal with carboxylic acids through mechanochemistry, which were considered unlikely by the molecular complementarity tool.
Experimental Section

Materials
Diflunisal (1) (MA -p), glutaric acid (GA -q), pimelic acid (PA -r), and fumaric acid (FA -s) were purchased from Sigma Aldrich. 4-Diamino-6-hydroxypyrimidine (DAHP -h) was purchased from Tokyo Chemical Industry (TCI, Europe). All chemicals were used without any further purification.
Solution co-crystallisation
1:1 molar ratios of 1 and the co-formers a (Py), b (Pbipy) and c (Ebipy) were dissolved in methanol/acetonitrile (1:1), with stirring and gentle heating. Crystalline adducts were obtained through slow evaporation of the solvent mixture. Similar experiments were carried out using other coformers but were unsuccessful in producing single crystals. To study the additive effect of e (OA), 1 and 10 % e were dissolved in ethanol, both with stirring and gentle heating, followed by slow evaporation.
Ball milling
Ball milling experiments with a 1:1 ratio of 1 and co-formers e-s and 1:1 and 2:1 ratios for the dipyridyl co-formers (b-d) and Py (a) were carried out at various time intervals, at 25 Hz using a Retsch ball mill. For long duration of milling the jars were allowed to cool for 15 min after every 30 min milling. Cryo-milling was carried out on 1:1 combinations of 1 and the carboxylic acid coformers using the same mill, for different times. The jars were initially immersed in liquid nitrogen for 5 min and the millings were carried out in intervals of 7.5 min and the jars were cooled in between for 2.5 min. The measured external temperature of the jars did not rise above -20 °C during cryo milling.
Single crystal X-ray diffraction
Single crystal diffraction data of all crystalline adducts were collected using an Oxford Diffraction Xcalibur CCD diffractometer using graphite-monochromated Mo-Kα radiation ( = 0.71073 Å) at room temperature (1a) or 150 K (1b, 1c). The structures were solved using SHELXT, 37 embedded in the OSCAIL software. 38 Non-hydrogen atoms were refined anisotropically and hydrogen atoms were in calculated positions. Graphics were produced with ORTEX and POGL also embedded in OSCAIL.
Crystallographic data can be found in 
X-ray powder diffraction (XRPD)
X-ray powder patterns were recorded on an Inel Equinox 3000 powder diffractometer between 5 and 90  (2θ) using Cu Kα radiation ( = 1.54178 Å, 35 kV, 25 mA). Theoretical powder patterns were calculated using the OSCAIL software. 38 
Differential scanning calorimetry (DSC)
DSC experiments were performed on a STA625 thermal analyzer from Rheometric Scientific (Piscataway, New Jersey). The heating rate was kept constant at 10 °C/min and all runs were carried out between 25 °C and 250 °C. The measurements were made in open aluminium crucibles, nitrogen was purged in ambient mode and calibration was performed using an indium standard.
Scanning electron microscopy (SEM)
The images were captured using a Hitachi S2600N Variable Pressure Scanning Electron Microscope with a backscatter BSE resolution of 20 nm at 25 kV, X 903 magnification, with an accelerating voltage of 5 kV, an emission current of 10000 nA at a working distance of 13.5 mm.
Computational studies
Molecular complementarity
The Molecular Complementarity tool in the Mercury software 25 was used to identify potential coformers for the co-crystallisation of 1. This was carried out using the database of potential targets supplied by the database, and a few other structures were loaded as their .mol files saved using the Avogadro software. 39 CSD search for motifs A motif search for three types of H-bonded adducts shown in Chart 2 was carried out, using the Conquest software. 40 One moiety in each case was an ortho-hydroxy benzoic acid, while the second moiety was either a structure with an aromatic N, forming a 1D hydrogen bond with the acid or another carboxylic acid group forming a dimer with the acid. The criteria used for the search were that the interactions are within a distance of the sum of the vdW radii +1 Å, an R-factor < 7.5%, and organometallics were excluded. The results, in the form of descriptors, from the searches were then exported to the Mercury software, where descriptive statistical analysis and principal component analysis 41 of Z', hydrogen bonding distances, number of unique chemical units, and the number of coordinates were carried out.
Gaussian calculations
Gaussian calculations were carried out on the individual molecules (1, a -e) and their adducts with a subset of the co-formers (a -e), in the gas phase, using density functional theory (DFT). The B3LYP functional was employed with two different basis sets, 6-311+g(d,p) and cc-pvtz. The structures were optimised for lowest energy and checked for the absence of negative frequencies. Simple formation energies were calculated from the minimized energies.
Stacking analysis
Stacking analysis 1 was performed on the obtained structures using OSCAIL. 38 The vdW distances of a molecule to its nearest neighbours in potential stacks were calculated. one disordered F in the structure was replaced with a H to simplify the calculation. PIXEL calculations on the other crystalline adducts were not possible as they had a Z' > 2.
Results and Discussion
The promiscuity of drug molecules in co-crystal formation and the efficient use of supramolecular synthons have been a topic of wide interest for the past decade. Shattock et al. 43 were actually in-plane interactions.
We carried out principal component analysis (PCA) on our searches based on motifs I and II in Chart 2 separately, using the tools available in Mercury. The descriptors used for the PCA were Z', distances (the H-bond distances between the H and the acceptor -1 length in motif I and 2 in motif II), the number of atomic co-ordinates in the unit cell, and the number of unique chemical units.
The COOH… Nar interactions:
The PCA gave a cumulative variance of 100% for the first four PCs.
PC1 (49.4% explained variance) was influenced surprisingly by Z' and the number of co-ordinates, PC2 (24.7% explained variance) has a contribution from the number of unique chemical units. This is apparent from Figure 1a , where the data points are sorted into three distinct layers along the y-axis denoting PC2. It is only PC3 (18.5% explained variance), perhaps surprisingly, that has any contribution from the H-bonding distances. This is because the COOH…N distances are very consistent (1.6 -1.8 Å) and thus do not contribute to variance. There are three exceptions here that have distances in the range of 2.3 -2.6 Å. However, these systems contain pyridine N-oxide.
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The COOH…COOH interactions: PCA gave a cumulative explained variance of 99% for the first 
Studies based on diflunisal
Molecular complementarity calculations revealed that 1 was likely to form co-crystals with coformers which had 'N' acceptors, rather than dicarboxylic acids, with exceptions of adipic acid (n) and benzoic acid (not studied here). This method makes use of multivariate analysis of the structures in the database, and projecting the current data to find a possible co-crystallisation hit. The data used are various properties, as well as crystallographic information. 24 Table S2 (SI) lists the possible hits predicted using this method. These predictions were tested by carrying out a series of cocrystallisation studies by ball milling and solution crystallisation of 1 with the co-formers listed above.
Solution crystallisation
Crystals of 1a (Dif-Py), 1b (Dif-Pbipy), and 1c (Dif-Ebipy) were obtained from a mixture of 1:1 acetonitrile and methanol and the crystal habits were distinctly different from that of 1, especially in the case of 1a and 1b. The crystallographic information for 1a-1c are summarised in Table 1 . Figure   2 illustrates the crystal packing observed in 1a, 1b and 1c. While 1a is a co-crystal, 1b and 1c are salts where the proton from the carboxylic acid has been transferred to the N in the co-former. In all three cases the H bonding motifs observed are linear chains of the co-formers with a molecule of 1 at both ends. This is due to competition between inter-and intra-molecular H-bonding possibilities present in the molecule of 1.
As can be seen from Figure 3a , 1a has a diamond-like habit. The crystal structure has an interleaved pattern with two molecules of 1 spaced by an a, with a 1-a distance of 3.7 Å. Figure 3b shows that 1b forms plate like crystals, crystallising in a monoclinic (P21/c) system. It has a rather large unit cell, which comprises of one molecule of b and two molecules of 1, with the ring carrying the carboxylic acid in 1 being co-planar to the pyridyl rings in b. 1c on the other hand forms needles like 1 itself does, and crystallises in the triclinic (P-1) system. 1c also has a molecule of the solvent acetonitrile included in its unit cell. 1a and 1c are stable, while 1b is very hygroscopic and is unstable when the solvent is removed.
To understand the direction and mechanism of growth in these systems, stacking analyses were carried out using the OSCAIL software. 1 Table 2 gives a comparative account of the percentage of vdW interactions observed in the crystal lattices along all axes. For a stacking interaction to dominate crystal growth it is normally found that more than 50% of the atoms in a molecule are in vdW contact with their neighbours above and below them in a stack. 1 In the case of the crystal form of 1, 46 Another interesting feature of these crystalline adducts is the absence of disorder with respect to the F atoms of 1. In the crystal structures of 1 (form I -FAFWIS01 and form IV -FAFWIS) the ortho F atom is disordered. This apparent disorder is due to the availability of space for torsion of the Fcarrying phenyl ring. In 1a, 1b and 1c, the ortho F is present on the side having the carboxylic acid unit in the adjacent ring. The formation is such that there is a pocket of C-F and C-H bonds, with the shortest C-H…F distance being 2.5 Å and largest F -F distance 5 Å and shortest 3.68 Å. Usually an F…H interaction is not considered significant due to the nature of F, 47 but here the short C-H…F distance, 2.5 Å, indicates a weak interaction (vdW sum 2.67 Å) that seems to be vital in preventing the disorder. In rare occasions, aromatic fluorine substitutions, due to the weak F…H interactions can affect optimal geometries of structures. 47 Such a feature was also identified by Bag et al. Table 3 lists the interaction energies of a central molecule of 1 with its next nearest neighbours in the co-crystal 1a. PIXEL energies for 1 and the co-formers (a -e) can be found in the SI (Tables S4 -S10 ). On comparison of the energy involved in 1 (-114.5 kJ/mol) with that of a (-59.7 kJ/mol) and 1a (-63.9 kJ/mol), it becomes apparent that there is no thermodynamic advantage for the formation of the co-crystal, as reported in the literature by Chan et al. using DFT-D methods. 23 Gavezzotti et al. in their recent study 45 surveyed the CSD for co-crystals and carried out CLP calculations on 97 structures. They found that the lattice energies of the co-crystals were invariably more stabilising than the lattice energies of the components themselves. Their finding would suggest that even though the formation energies of the hetero-adducts are higher than that of their individual components, there is increased stability due to crystal packing effects. Unfortunately, they were not able to survey pharmaceutical co-crystals in any great length due to the presence of multiple functional groups.
While dispersion energies are dominant in the crystal structure of a, combined with the fact that it has low lattice energies, gives it an advantage in forming 1a. The crystal structure of 1 is however, dominated by the Coulombic energy of the (8) 2 2
H-bond dimer it forms with itself, followed by the dispersion energy of stack formation. Figure 4 illustrates the interactions observed in the 1a crystal,
showing the origin of the dispersion and Coulombic energies.
DFT calculations on the H-bonded adducts studied using Gaussian reveal a similar result. The formation energies calculated for adducts are much smaller than that of the 1-dimer, except for the case of the 1-e adduct, which had very similar formation energies to that of the 1-dimer itself. The formation energies for all adducts can be found in Table S11 (SI). It has to be noted that the gas phase calculations do not take the proton transfer in 1b and 1c into account, i.e. the formation of charge-
assisted H bonds. Arderne et al. through their calculations have shown that charge-assisted H-bonding
tends to give adducts an extra 13 -14 kJ/mol stabilisation compared to their neutral versions. 48 Adding in the extra 13 kJ/mol to the formation energies of 1b and 1c would still make their formation energy similar to and slightly higher than that of 1 itself. The fact that these adducts have lower formation energies suggests that their formation may well be driven by entropy, which would favour a heterosynthon over a homosynthon. It would also suggest that, being less stable than 1 itself, the adducts should have enhanced dissolution properties and hence be more bioavailable. In the case of oxalic acid the formation energies were very similar to that of the 1-dimer and yet it did not produce co-crystals in solution. In this case, there is no advantage in terms of formation energies due to the presence of COOH…COOH dimers and the entropy difference should also be small.
While further crystallisation studies were carried out using the other co-formers, they were not successful in producing co-crystals or salts. However, oxalic acid (e) had an interesting effect in the crystallisation of 1. 1 is known to produce crystals of polymorph III (FIII) in pure ethanol. 46 However, in the presence of 10-50 % oxalic acid we observed the formation of form I (FI) in the same solvent.
FI was identified by indexing single crystals on a diffractometer. FI is generally crystallised from toluene or from a mixture of benzene and methanol. 46 Using e as an additive this polymorph can be obtained from the greener solvent ethanol. Thomas et al. have made similar observations in the cases of paracetamol, 49 piroxicam, 50 and gallic acid, 50 where the presence of a large amount of co-former led to the formation of rare or previously unknown polymorphs. However, they have not been able to identify a mechanism for this behaviour. Due to large quantities of the co-former required, as opposed to the small amounts of additives generally known to affect nucleation events, we hyptothesize that the effect of the co-former might actually be a crystal growth effect.
Together with the experimental observations and the findings of the DFT calculations showing very similar formation energies for both the 1 homodimer and 1e hetero-adduct, it would seem that, in the presence of a co-former, the increase in entropy presents no advantage for the formation of cocrystals, as the enthalpy of formation dominates the thermodynamics of the system. It has been observed through ball milling (which we discuss in the next section), that 1e co-crystals are formed on milling. This would suggest that the co-crystal may have very high solubility at room temperature, preventing its crystallisation. The reason for large quantities of co-former causing a change in polymorph of the drug, is not currently understood, but further studies on this phenomenon are being carried out.
After a few months in contact with solution, a few plates of FIV were also found amongst the FI needles. In the absence of oxalic acid FIV rapidly crystallises as needles. The transformation to the more thermodynamically favoured plates is a slow process. Previously, alkanoic carboxylic acids have been used as additives by Davey et al. 51 in small quantities to modify the morphology of adipic acid. They observed an increase in the aspect ratio of the crystals, eventually leading to the formation of twin crystals of adipic acid in the presence of alkanoic acid. A long established example is that of urea modifying the morphology of NaCl crystals. Smith et al. have recently carried out theoretical and computational studies to understand the effect urea has on crystal growth. 52 They identify that urea preferentially stabilises octahedral NaCl, by raising the chemical potential of all faces; however, the 111 face was the most stable.
Ball milling
Mechanochemistry, due to its non-equilibrium nature, is often employed to produce polymorphs 6 and co-crystals 53 Co-milled 1 and g (HP) in a 1:1 ratio results in a new XRPD pattern ( Figure S13, SI) suggesting the formation of a new co-crystalline adduct. This is further supported by the thermal analysis ( Figure   S14 , SI) where the material shows an endothermic peak at 187 °C, followed by melting at 202 °C.
These thermal events are different from the starting materials, where g is known to melt at 107 °C. HP exhibits lactam-lactim tautomerism. Both tautomers can interact with a carboxylic acid via an (8)
The case of oxalic acid (e) is very interesting. While the molecular complementarity tool in the Mercury software predicted a 0% probability of co-crystal formation, ball milling of 1:1 ratios of 1 and e resulted in a new pattern as shown in Figure 5 , suggesting the formation of a 1:1 adduct.
Thermal analysis of the milled material revealed four thermal events, each with an associated weight loss (Figure 6) . The peak at 67 °C corresponds to the loss of 1.5% adventitious water. The second event occurs at 171 °C, with a 15.5% weight loss, that corresponds to the loss of half of e present in the system. The third thermal event occurs at 199 °C, with a weight loss of 27.2%, that corresponds to the loss of all e molecules, followed by the melting of 1 at 213 °C. The absence of the melting endotherm of e (m.p. 202 -203 °C) and the loss of half of e at 171 °C suggests the transformation of 1e from a 1:1 composition to a 2:1 adduct. This is supported by the XRPD patterns. To understand the change in composition better, the 1:1 co-milled sample was held at 100 °C for 30 min and a second sample at 100 °C for 30 min followed by 30 min at 180 °C. The XRPD patterns ( Figure 5 ) reveal the formation of both 1:1 and 2:1 adducts. Another experiment was carried out where a 1:1 mixture of 1 and e (dihydrate form) was milled for 120 min without any cooling interval. This resulted in a bright purple sample (Figure S15 ), which could suggest the presence of a high degree of disorder in the structure. 54 The XRPD pattern (Figure 5, D) is almost identical to that of FIII with the exception of a new peak at 21° (2θ). The thermal analysis however, revealed the presence of a co-crystal that melts at 178 °C, with two other recrystallisation events. Together with the fact that the material melts at a temperature different to that of its starting material and that there is no weight loss involved in either of the thermal events, it can be safely concluded that this is a polymorph of 1e. Seeded crystallisation experiments using crystals from the milled sample were unsuccessful.
In contrast to all other co-milling experiments, milling a 1:1 mixture of 1 and h (DAHP) did not yield an XRPD pattern. Only an amorphous halo was observed and no Bragg peaks appeared during storage for over 6 months ( Figure S16 ). It is possible that crystallisation was effectively blocked by the multifunctional h, which has three H-bond donors and two acceptors, which could stabilize an amorphous phase by disrupting the formation of the acid dimers. In the interesting case of 1e, milling for 120 min without intermittent cooling (Figure 8a ) seems to lead to some kind of melting resulting in an amorphous looking material, from which some tape like features are growing. The 1:1 sample milled for 60 min with intermittent cooling, followed by heating at 100 °C (Figure 8b) shows features similar to those in Figure 7 . The sample heated at 180 °C that results in the 2:1 adduct as established by DSC shows the formation of large well defined blocks or plank like crystals. This could be an effect of the annealing process which could have led to the formation of these blocks that deviate from the normal needle like structures.
Co-milling of 1 with carboxylic acids i -s did not yield any co-crystals. Co-milling 1 and s resulted in an X-ray amorphous material that crystallises back to its constituents. XRPD patterns for these samples are shown in Figures S23 -S33 (SI) . Cryo-milling of these systems gave results that were similar to the room temperature studies (data not shown). A discrepancy with the predictions of the molecular complementarity tool in the Mercury software is the non-occurrence of co-crystals of n and r, either through milling or solution crystallisation, despite a prediction with a 100% hit rate. This tool however, has been successful in predicting co-crystallisers for diflunisal in 11 out of 14 cases the exceptions being oxalic acid, adipic acid and pimelic acid.
Conclusions
Ball milling diflunisal with a range of bipyridines, p-aminobenzoic acid and oxalic acid led to the formation of eight co-crystals.
Solution crystallization of diflunisal with pyrazine gave a co-crystal (1a) and a salt with 1,3-di(4-pyridyl)propane (1b) both of which unlike diflunisal do not show needle growth. However, 
